ELITE PHARMACEUTICALS INC /DE/ 4
4 · ELITE PHARMACEUTICALS INC /DE/ · Filed Sep 1, 2005
Insider Transaction Report
Form 4
NEUGEBOREN EDWARD
Director
Transactions
- Award
Option
2005-08-30$2.75/sh+30,000$82,500→ 177,363 totalExercise: $2.75Exp: 2005-08-30→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]1/3 of the options shall vest during the period commencing on August 30, 2006, 1/3 of the options shall vest during the period commencing on August 30, 2007 and the remaining 1/3 of the options shall vest during the period commencing on August 30, 2008.
- [F2]This amount includes the following previously reported derivative securities (i) warrant to purchase 117,733 shares of common stock at $1.23 exercise price, (ii) warrant to purchase 25,546 shares of common stock at $1.40 exercise price and (iii) warrant to purchase 4,084 shares of common stock at $1.47 exercise price. The reporting person also beneficially owns 20,325 shares of common stock.